Abeona Therapeutics Inc 's Revenue in the fiscal year 2025 $ 11.38 millions
Abeona Therapeutics Inc 's Revenue in the fiscal year 2024 $ 4.25 millions
Abeona Therapeutics Inc 's Revenue in the fiscal year 2023 $ 5.62 millions
Abeona Therapeutics Inc 's Revenue in the fiscal year 2022 $ 1.85 millions
Abeona Therapeutics Inc 's Revenue in the fiscal year 2021 $ 3.00 millions
ABEO Revenue second quarter 2026 Y/Y Growth Comment
Abeona Therapeutics Inc achieved in the second quarter 2026, above Company average Revenue surge of 695.8% year on year, to $ 11.38 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 17 other companies have achieved higher Revenue growth. While Abeona Therapeutics Inc ' s Revenue doubling of 695.8% ranks overall at the positon no. 67 in the second quarter 2026.
ABEO Revenue ( Y/Y Growth %)
2026
2025
2024
2023
4th Quarter
December
-
583.33 %
37.84 %
72.09 %
3rd Quarter
September
-
40.34 %
101.69 %
742.86 %
2nd Quarter
June
695.8 %
20.17 %
-69.64 %
292 %
1st Quarter
March
668.7 %
55.95 %
133.33 %
2.86 %
FY
-
168.4 %
-24.42 %
-
Financial Statements
Abeona Therapeutics Inc 's second quarter 2026 Revenue
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Abeona Therapeutics Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
976.1 %
60.37 %
-100 %
(Jun 30 2023)
ABEO's II. Quarter Q/Q Revenue Comment
Abeona Therapeutics Inc achieved in the II. Quarter 2026 below company average Revenue rise of 13.01% quarter on quarter, to $ 11.38 millions.
Although the II. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 9.16% growth in the II. Quarter a year ago
Within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Abeona Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 708.
Abeona Therapeutics Inc achieved in the II. Quarter 2026 below company average Revenue rise of 13.01% quarter on quarter, to $ 11.38 millions.
II. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 9.16% in the II. Quarter a year ago.
Within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Abeona Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 708.
Abeona Therapeutics Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 30.09
$ 20.14
$ 11.38
$ 5.43
$ 4.95
Y / Y Revenue Growth (TTM)
508.06 %
327.33 %
167.92 %
36.96 %
46.85 %
Year on Year Revenue Growth Overall
Ranking
# 65
# 128
# 411
# 323
# 3564
Seqeuential Revenue Change (TTM)
49.42 %
77.04 %
109.43 %
9.76 %
5.01 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 65
# 128
# 411
# 323
# 3564
Cumulative Revenue growth Comment
Abeona Therapeutics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 508.06% year on year, to $ 30 millions if the fiscal year would have ended in Jun 30 2026. Abeona Therapeutics Inc 's trailing twelve months Revenue growth was higher than company's average 58.58% and higher than 327.33% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 49.42 % from $20.14 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at58.58%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 49.42 % increase from $20.14 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 65, from total ranking in previous quarter at 128.
Abeona Therapeutics Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 508.06% year on year, to $ 30 millions if the fiscal year would have ended in Jun 30 2026. Abeona Therapeutics Inc 's trailing twelve months Revenue growth was higher than company's average 58.58% and higher than 327.33% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 49.42 % from $20.14 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at58.58%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 49.42 % increase from $20.14 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 65, from total ranking in previous quarter at 128.
About Abeona Therapeutics Inc Revenue Growth Rates (ABEO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1,150.00%